UNIGE document Scientific Article
previous document  unige:95508  next document
add to browser collection
Title

Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study

Authors
Altomare, Daniele
Ferrari, Clarissa
Festari, Cristina
Guerra, Ugo Paolo
Paghera, Barbara
Pizzocaro, Claudio
Lussignoli, Giulia
show hidden authors show all authors [1 - 46]
Published in JAMA Neurology. 2016, vol. 73, no. 12, p. 1417-1424
Abstract Cerebral amyloidosis is a key abnormality in Alzheimer disease (AD) and can be detected in vivo with positron emission tomography (PET) ligands. Although amyloid PET has clearly demonstrated analytical validity, its clinical utility is debated.
Keywords AgedAged, 80 and overAlzheimer Disease/diagnosis/diagnostic imaging/metabolismAmyloid beta-Peptides/metabolismAniline CompoundsCognitive Dysfunction/diagnosis/diagnostic imaging/metabolismEthylene GlycolsFemaleHumansMalePositron-Emission Tomography/methods/standardsPredictive Value of Tests
Identifiers
PMID: 27802513
Full text
Article (Published version) (488 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Troubles de mémoire et maladie d'Alzeimer (935)
Citation
(ISO format)
BOCCARDI, Marina et al. Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. In: JAMA Neurology, 2016, vol. 73, n° 12, p. 1417-1424. https://archive-ouverte.unige.ch/unige:95508

8 hits

0 download

Update

Deposited on : 2017-07-20

Export document
Format :
Citation style :